HSBC TO. BULL NESR/ DE000TD8DNZ0 /
20/12/2024 15:40:11 | Var.-0.0600 | Denaro17:18:53 | Lettera17:18:53 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
2.6100EUR | -2.25% | 2.6500 Quantità in denaro: 10,000 |
2.6900 Quantità in lettera: 10,000 |
NESTLE N | 49.1412 CHF | 31/12/2078 | Call |
GlobeNewswire
13/08
Seres Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates
GlobeNewswire
06/08
Seres Therapeutics Announces Signing of VOWST™ Asset Purchase Agreement with Nestlé Health Science
GlobeNewswire
23/07
Mondelēz International Names Filippo Catalano Chief Information and Digital Officer
GlobeNewswire
12/06
NFWF Announces $10.2 Million in Grants to Cultivate Conservation Practices on Agricultural Lands
GlobeNewswire
06/06
Seres Therapeutics Enters Into Memorandum of Understanding For Vowst™ Asset Sale to Nestlé Health Sc...
GlobeNewswire
26/03
NESTLE INTERNATIONAL AWARDED OMNIQ A PURCHASE ORDER FOR THE SUPPLY OF RUGGEDIZED IOT EQUIPMENT TO NE...
GlobeNewswire
19/03
VML Augments Digital Commerce Capabilities by Forging Partnership with CommerceIQ’s Unified Artifici...
GlobeNewswire
04/03
Blender Bites to Launch Co-Branded Product with Orgain, the #1 Selling Plant-based Protein Brand in ...
GlobeNewswire
13/02
Corporate Alignment with Climate Goals Under Scrutiny: LyondellBasell & Bayer demonstrate good pract...
GlobeNewswire
23/01
Nestlé Joins Growing List of National and Multinational Companies Operating at the Tejon Ranch Comme...
GlobeNewswire
27/12/2023
Codexis Announces Purchase Agreement with Nestlé Health Science for CDX-7108